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he cascade of phosphorylation is a pivotal event in trans-
forming growth factor 
 
 
 
 (TGF
 
 
 
) signaling. Reversible
phosphorylation regulates fundamental aspects of
cell activity. TGF
 
 
 
-induced Smad7 binds to type I receptor
(TGF
 
 
 
 type I receptor; T
 
 
 
RI) functioning as a receptor kinase
antagonist. We found Smad7 interacts with growth arrest
and DNA damage protein, GADD34, a regulatory subunit
of the protein phosphatase 1 (PP1) holoenzyme, which
subsequently recruits catalytic subunit of PP1 (PP1c) to
dephosphorylate T
 
 
 
RI. Blocking Smad7 expression by RNA
interference inhibits association of GADD34–PP1c complex
T
 
with T
 
 
 
RI, indicating Smad7 acts as an adaptor protein in
the formation of the PP1 holoenzyme that targets T
 
 
 
RI for
dephosphorylation. SARA (Smad anchor for receptor acti-
vation) enhances the recruitment PP1c to the Smad7–
GADD34 complex by controlling the speciﬁc subcellular
localization of PP1c. Importantly, GADD34–PP1c recruited
by Smad7 inhibits TGF
 
 
 
-induced cell cycle arrest and
mediates TGF
 
 
 
 resistance in responding to UV light irradi-
ation. The dephosphorylation of T
 
 
 
RI mediated by Smad7
is an effective mechanism for governing negative feedback
in TGF
 
 
 
 signaling.
 
Introduction
 
TGF
 
 
 
 superfamily members regulate cell fate by controlling
proliferation, differentiation, and apoptosis and are therefore
crucial for the development and maintenance of many different
tissues (Derynck, 1994; Heldin et al., 1997; Kretzschmar
and Massague, 1998; Miyazono, 2000; Attisano and Wrana,
2002). Deregulated TGF
 
 
 
 family signaling has been impli-
cated in various human diseases, including autoimmune
diseases, vascular disorders, and cancers (Derynck et al.,
2001; Attisano and Wrana, 2002). TGF
 
 
 
 superfamily mem-
bers elicit their cellular response through ligand-induced
formation of heteromeric complexes of specific transmem-
brane types I and II kinase receptors. The type II receptor is a
constitutively active kinase, which upon ligand-mediated
heteromeric complex formation phosphorylates particular
serine and threonine residues in the type I receptor juxta-
membrane region (GS domain; Wieser et al., 1995), resulting
in the activation of the type I receptor (Wrana et al., 1992,
1994a; Franzen et al., 1993). The activated type I receptor
then transiently associates with and phosphorylates a subclass
of a unique family of intracellular signaling molecules called
Smad proteins. This subclass of Smads are receptor-regulated
Smads (R-Smads; Heldin et al., 1997; Kretzschmar and
Massague, 1998; Attisano and Wrana, 2002). Once phos-
phorylated by activated type I receptor at their COOH-ter-
minal SSXS motif, R-Smads rapidly dissociate from the recep-
tor to form complexes with common partner Smad, Smad4,
and migrate into the nucleus where they regulate transcription
of target genes (Derynck, 1994; Heldin et al., 1997; Attisano
and Wrana, 2002). Thus, the activity of this pathway is
tightly controlled by serine/threonine phosphorylation, which
plays a key role in regulating protein–protein interactions
that are critical in the elaboration of signaling responses
(Derynck, 1994; Heldin et al., 1997; Miyazono, 2000; Atti-
sano and Wrana, 2002).
With no exception, the phosphorylation state of cellular
proteins is controlled by the opposing actions of protein
kinases and phosphatases. There are two kinds of kinase/
phosphatase in the mammalian system: protein tyrosine
kinase/protein tyrosine phosphatase (PTP) and serine threo-
nine kinase/protein phosphatase (PP). Receptor protein ty-
rosine kinases are all type I transmembrane proteins with a
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cytoplasmic domain that has an intrinsic catalytic activity ac-
tivated upon ligand binding. These phosphorylated substrates
can hence be dephosphorylated by certain PTPs (Egloff et al.,
1997; Bollen, 2001; Attisano and Wrana, 2002; Cohen,
2002). Mammalian members of the receptor serine threonine
kinase family are receptors for ligands of TGF
 
 
 
 family. The
counterpart of PTP here is protein phosphatase (PP), but no
protein phosphatase was found directly involved in the de-
phosphorylation of major components in the TGF
 
 
 
 signaling
pathway.
Here we show that Smad7, an inhibitory Smad whose ex-
pression is induced by TGF
 
 
 
 (Hayashi et al., 1997; Nakao
et al., 1997), interacts with growth arrest and DNA damage
protein (GADD34; Hollander et al., 1997; Liebermann and
Hoffman, 2002), a regulatory/targeting subunit of the pro-
tein phosphatase 1 (PP1) holoenzyme (Egloff et al., 1997;
Aggen et al., 2000; Bollen, 2001; Cohen, 2002). The cata-
lytic subunit of PP1, PP1c, is recruited to TFG
 
 
 
 type I
receptor (T
 
 
 
RI)–Smad7–GADD34 complex through this
regulatory subunit, GADD34, to dephosphorylate T
 
 
 
RI.
Furthermore, GADD34 is induced by UV light irradiation
along with Smad7 resulting UV light–induced TGF
 
 
 
 resis-
tance in Mv1Lu cells. Blockage of GADD34 and Smad7 by
RNA interference (RNAi) restores the resistance to TGF
 
 
 
.
Together, these results indicate that the formation of PP1
holoenzyme mediated by TGF
 
 
 
-induced Smad7 functions
as a negative feedback in TGF
 
 
 
 signaling pathway by de-
phosphorylating T
 
 
 
RI. This implies an important mecha-
nism by which TGF
 
 
 
 regulates the development, mainte-
nance, and tumorigenesis of different tissues.
 
Results
 
GADD34 functions as a Smad7-interacting protein 
through its central repeats
 
Although the phosphorylation cascade of TGF
 
 
 
 signaling is
well characterized, little is known about the negative regula-
tory mechanism by phosphatases. To investigate the possible
dephosphorylation mechanism of TGF
 
 
 
 signaling, we used
the full length of Smad7 cDNA as a bait to screen a human
chondrocyte cDNA library in a yeast two-hybrid system. Se-
quence analysis revealed that two of the positive clones were
Figure 1. GADD34 as a Smad7-interacting protein through 
its central repeats. (a) GADD34 is shown schematically with 
conservative regions. Two fragments of GADD34 were isolated 
in a yeast two-hybrid screen using Smad7 as the bait. (b–e) 
Smad7 interacts with GADD34 in mammalian cells. (b and c) 
Immunoblots indicating the protein expression levels of the 
lysates of COS1 cells transfected with HA–GADD34 and Flag–
Smad7 or HA–GADD34 fragment 2 are shown in the two lower 
panels. The upper panel shows anti-Flag immunoprecipitates 
probed with anti-HA antibody (b) or anti-HA immunoprecipitates 
probed with anti-Flag antibody (c). The bands at  50 kD close to 
Smad7 in immunoprecipitate lanes were due to the presence of 
cross-reacting Ig heavy chain. (d and e) Endogenous GADD34 immunoprecipitated from Mv1Lu cells coprecipitated Smad7 as determined by 
immunoblotting. Conversely, immunoprecipiated endogenous Smad7 coprecipitated GADD34. (f and g) Similar experiments were performed 
in both yeast (f) and mammalian (g) systems to map Smad7 binding to GADD34. 
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GADD34 and that both clones contain the GADD34 cen-
tral repeat region (He et al., 1996; Hollander et al., 1997;
Liebermann and Hoffman, 2002; and Fig. 1 a). 
 
 
 
-Galactosi-
dase liquid assays showed that Smad7 interacts with full-
length GADD34, suggesting that the GADD34 central re-
peats mediate the interaction (Fig. 1 a).
Flag-tagged Smad7 was then cotransfected with HA-
tagged GADD34 in COS1 cells to confirm the interaction
in mammalian cells. The cell lysate was subjected to Smad7
immunoprecipitation and the associated GADD34 was im-
munoblotted. Conversely, GADD34 was immunoprecipi-
tated and Smad7 was immunoblotted. The results showed
that Smad7 coprecipitated with GADD34 (Fig. 1, b and c).
The interaction was further confirmed with endogenous
Smad7 and GADD34 and TGF
 
 
 
 significantly enhanced
the interaction (Fig. 1, d and e). This is likely a result of
TGF
 
 
 
-induced Smad7 transcription (Hayashi et al., 1997;
Nakao et al., 1997). To verify that GADD34 central
repeats mediate the interaction, a series of truncated
GADD34 plasmids were generated in both yeast two-
hybrid and mammalian expression vectors. Consistent with
library screen results, deletion of the GADD34 multiple
34–aa repeats abolished its interaction with Smad7 and a
single repeat was not sufficient to mediate the interaction
(Fig. 1 f). Immunoprecipitation assays with the same deletion
constructs indicated that the GADD34 multiple 34–aa re-
peat mediates the interaction with Smad7 (Fig. 1, b and c,
last lanes, and Fig. 1 g).
 
TGF
 
 
 
 regulates the formation of T
 
 
 
RI–Smad7–GADD34 
complex via Smad7
 
Because Smad7 acts as an antagonist in the TGF
 
 
 
 signaling
pathway by binding to the T
 
 
 
RI (Wrana et al., 1994a,b;
Wieser et al., 1995; Feng and Derynck, 1997; Attisano and
Wrana, 2002), and GADD34 is a targeting subunit of PP1
(He et al., 1996; Hollander et al., 1997; Novoa et al., 2001;
Liebermann and Hoffman, 2002), the interaction of Smad7
with GADD34 implicates a negative regulatory mechanism
via the dephosphorylation of T
 
 
 
RI. Recent studies have re-
vealed that PP1 negatively regulates decapentaplegic signal-
ing in 
 
Drosophila melanogaster
 
 by affecting the phosphoryla-
tion state of T
 
 
 
RI (Bennett and Alphey, 2002). We
therefore examined whether TGF
 
 
 
 mediates the binding of
GADD34–PP1c serine/threonine phosphatase to its sub-
strate, T
 
 
 
RI, because GADD34 is a target regulatory sub-
unit of the PP1 holoenzyme. First, we examined whether
GADD34 forms complexes with T
 
 
 
RI and Smad7 in mam-
malian cells. Immunoprecipitation assays were performed
in TGF
 
 
 
-responsive MvlLu cells treated with or with-
out TGF
 
 
 
-1. TGF
 
 
 
-induced endogenous T
 
 
 
RI–Smad7–
GADD34 complexes were immunoprecipitated with either
anti-T
 
 
 
RI or anti-GADD34 antibody (Fig. 2, a and b).
This complex is further confirmed by a sequential immu-
noprecipitation. COS1 cells were first cotransfected with
T
 
 
 
RI–HA and PP1c with or without Flag–Smad7 and
GADD34. After 2 h of stimulation with TGF
 
 
 
-1, the cells
were lysed, subjected to first immunoprecipitation with Flag
Figure 2. TGF  regulates the formation 
of T RI–Smad7–GADD34 complexes 
via Smad7. (a) Endogenous T RI was 
immunoprecipitated from Mv1Lu cells 
with or without TGF -1 stimulation and 
precipitates were examined for the 
presence of GADD34 and Smad7 by 
immunoblotting. (b) Conversely, endog-
enous GADD34 was immunoprecipiated 
from Mv1Lu cells with or without TGF -1 
stimulation and precipitates were 
examined for the presence of T RI 
and Smad7. (c and d) Experiments 
were performed in both yeast (c) and 
mammalian (d) systems, as in Fig. 1, 
to map GADD34 binding to Smad7. 
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antibody, and the resultant precipitates were eluted from the
protein G–Sepharose bead by Flag peptide competition and
then subjected to second immunoprecipitation with HA an-
tibody. The final precipitates were immunoblotted with an-
tibodies against all these components (Fig. 2 c). The results
indicated that the triple components complex, Smad7–
T
 
 
 
RI–GADD34, were formed along with PP1c. To iden-
tify the region of Smad7 that binds GADD34, a series of
truncated Smad7 truncation constructs were generated for a
yeast two-hybrid assay (Fig. 2 d). The results indicate that
the COOH terminus is responsible for the binding of
Smad7 to GADD34. Immunoprecipitation experiments fur-
ther corroborate the mapping results from yeast two-hybrid
assays (Fig. 2 e). Together, the results demonstrate that
T
 
 
 
RI forms complexes with GADD34 and that TGF
 
 
 
 en-
hances this interaction via Smad7, whose expression induced
by TGF
 
 
 
 enhances the complex formation (Fig. 2, a and b).
 
Smad7 regulates recruitment of PP1c 
to Smad7–T
 
 
 
RI–GADD34 complex
 
As a catalytic subunit of PP1, PP1c is recruited to
GADD34–Smad7–T
 
 
 
RI based on the sequential immuno-
precipitation result (Fig. 2 c). We then investigated how this
recruitment is regulated. MvlLu cells were treated with or
without TGF
 
 
 
-1. Cell lysates were immunoprecipitated
with anti-T
 
 
 
RI antibody followed by immunoblotting with
anti-PP1, anti-GADD34, and anti-Smad7 antibodies. Con-
versely, lysates were immunoprecipiated with anti-PP1c an-
tibody and immunoblotted with anti-T
 
 
 
RI, anti-GADD34,
and anti-Smad7 antibodies. The results demonstrate that
PP1 coprecipitates with the triple complex and that TGF
 
 
 
enhances the coprecipitation (Fig. 3, a and b). To determine
whether TGF
 
 
 
 regulates the interaction through Smad7, we
blocked Smad7 expression with Smad7 small interface RNA
(siRNA; Hannon, 2002; McManus and Sharp, 2002). Fig. 3
c shows that blocking of Smad7 expression inhibits the re-
cruitment of PP1c to the complex. Importantly, the amount
of PP1c in the complex is proportional to the expression
level of Smad7 (Hayashi et al., 1997; Imamura et al., 1997).
 
Dephosphorylation of T
 
 
 
RI 
by Smad7–GADD34–PP1c complex
 
Furthermore, we examined the potential dephosphorylation
of T
 
 
 
RI by Smad7-recruited PP1 complex. Purified GST–
T
 
 
 
RI–
 
32
 
P was incubated with HA antibody immunoprecipi-
tates from COS1 cells transfected with either HA–Smad7 or
GADD34 or in combination with PP1c (Fig. 4 a). Transfec-
tion with Smad7 or GADD34 alone did not cause consider-
able dephosphorylation of T
 
 
 
RI. Dephosphorylation of
T
 
 
 
RI was observed when both Smad7 and GADD34 were
overexpressed (Fig. 4, a and b, lane 5). With co-overexpres-
sion of PP1c or addition of recombinant rabbit PP1c (rR-
PP1c [0.05 
 
  
 
]), T
 
 
 
RI was significantly dephosphorylated
(Fig. 4, a and b, lanes 6 and 9), whereas addition of PP1 in-
hibitor 1 (I-1) inhibited T
 
 
 
RI dephosphorylation (Fig. 4, a
and b, lane 7). To confirm the observation in cells, MvlLu
cells were cotransfected with T
 
 
 
RI–HA, Smad7, GADD34,
and PP1c and various other combinations of the genes and
labeled with [
 
32
 
P]orthophosphate (Fig. 4 c). The cell lysates
were separated on a denatured gel and directly exposed to
x-ray film. Results similar to those described above were ob-
tained (Fig. 4, c and d, lanes 3–8). Okadaic acid (OA) was
used as a phosphatase inhibitor. Importantly, deletion of
COOH-terminal KVRF motif of GADD34 or the COOH
terminus of Smad7-inhibited dephosphorylation activity
(Fig. 4, c and d, lanes 9 and 10). PP1c alone did not cause
significant dephosphorylation of T
 
 
 
RI either in vitro or in
vivo (Fig. 4, a and b, lanes 4 and 8; Fig. 4, c and d, lane 5).
 
Regulation of PP1c intracellular localization close to 
Smad7–GADD34 complex by Smad anchor for 
receptor activation (SARA)
 
While pursuing the potential role of PP1c in T
 
 
 
RI signaling,
Bennett and Alphey reported that PP1c binds to SARA and
negatively regulates decapentaplegic signaling (Tsukazaki et
al., 1998; Bennett and Alphey, 2002). Expression of domi-
nant-negative SARA with a mutation in the PP1c-binding
domain (F678A) resulted in hyperphosphorylation of the
Figure 3. Smad7 mediates recruitment of PP1c to T RI. (a and b) 
TGF  regulates the interaction between T RI and PP1c. Endogenous 
T RI was immunoprecipitated from Mv1Lu cells with or without 
TGF -1 stimulation and precipitates were detected for the presence 
of PP1c, GADD34, and Smad7 by immunoblotting (a). Conversely, 
endogenous PP1 was immunoprecipitated and T RI, Smad7, and 
GADD34 detected by immunoblotting (b). (c) Knockdown of Smad7 
inhibits the formation of a GADD34–PP1c complex with T RI. 
(c) Endogenous Smad7 in 293T cells was knocked down by using 
siRNA in the presence or absence of TGF -1. The cell lysates were 
immunoprecipitated with anti-T RI and the presence of PP1c in the 
precipitate was detected by immunoblotting with anti-PP1.Dephosphorylation of T RI by GADD34–PP1c | Shi et al. 295
type I receptor and stimulated expression of a TGF  signal-
ing target (Bennett and Alphey, 2002). SARA is known to re-
cruit R-Smads to the TGF  receptor by controlling the sub-
cellular localization of R-Smads and by interacting with the
T RI complex (Tsukazaki et al., 1998). It also functions as
an anchor for PP1c via its PP1c-binding motif (Bennett and
Alphey, 2002). We first examined whether SARA–PP1c
complex is able to dephosphorylate T RI directly. Purified
GST–T RI–
32P was incubated with anti-Flag immunopre-
cipitates from cells transfected with Flag–GADD34, Flag–
SARA, or Flag–GADD34 with mammalian dominant-nega-
tive SARA (F728A) in combination with PP1c and Smad7.
SARA–PP1c complex did not show significant dephosphory-
lation of T RI in comparison to control and Smad7–
GADD34–PP1c complex (Fig. 5 a, lanes 1–3). These results
suggest that SARA is not likely a targeting subunit for direct-
Figure 4. Dephosphorylation of T RI 
by Smad7-recruited PP1 complex. 
(a and b) In vitro dephosphorylation assay. 
(a) GST–T RI was phosphorylated by an 
in vitro phosphorylation reaction. GST–
T RI–
32P was incubated with different 
immunoprecipitates (anti-HA) from 
lysates of COS1 cells transfected with 
different combinations of genes, in the 
absence or presence of phosphatase 
inhibitor (I-1) or recombinant rabbit 
PP1c (rR-PP1c) as indicated. (b) The 
relative 
32P phosphorylation level of the 
type I receptor in a, normalized to input 
of GST–T RI–
32P, is plotted as the 
mean   SD from three experiments. 
(c and d) In vivo dephosphorylation assay. 
(c) Mv1Lu cells transfected with different 
combination of genes were labeled with 
[
32P]orthophosphate in the presence or 
absence of TGF -1 as indicated. T RI–
HA was immunoprecipitated from lysates 
of treated cells and separated by 8.5% SDS-PAGE. Gels were dried and exposed to Biomax Mr film (Eastman Kodak).  GADD34 is a mutant 
without the PP1c binding domain and  Smad7 is absent in its T RI binding site. OA is an inhibitor for both PP1 and PP2. (d) The relative 
32P 
phosphorylation level of T RI in c was plotted as the mean   SD from three experiments.
Figure 5. The regulation of PP1 intra-
cellular localization and facilitation 
of T RI dephosphorylation by SARA. 
(a and b) SARA–PP1c fails to dephos-
phorylate T RI in vitro. (a) Similar in 
vitro dephosphorylation assay to that in 
Fig. 4 a was performed. GST–T RI–
32P 
was incubated with different immuno-
precipitates (anti-Flag) from lysates of 
COS1 cells transfected with different 
combinations of genes as indicated. In 
lanes 2 and 4 Flag was tagged to GADD34 
and in lane 3 Flag was tagged to SARA. 
In lane 4 SARA was replaced with DN–
SARA (F728A). (b) The relative 
32P phos-
phorylation level of the type I receptor in 
a, normalized to input of GST–T RI–
32P, 
is plotted as the mean   SD from three 
experiments. *P   0.05, compared with 
lane 2. (c) The availability of PP1 to the 
complex is mediated by SARA. COS1 
cells were transfected with either Flag–
WT–SARA or Flag–DN–SARA (F728A). 
The cell lysates were immunoprecipi-
tated with anti-PP1c, and the T RI, 
Smad7, and GADD34 in the precipitate 
were probed by immunoblotting. (d and e) 
In in vivo dephosphorylation assay, 
dominant-negative SARA with a mutation 
in the PP1c-binding domain (F728A) 
inhibits the dephosphorylation of T RI by 
Smad7-recruited PP1 complex. (d) Similar 
experiments to that in Fig. 4 c were performed with dominant-negative SARA (F678A). (e) The relative 
32P phosphorylation level of T RI in 
panel d was plotted as the mean   SD from three experiments. *P   0.05, compared with lane 3.296 The Journal of Cell Biology | Volume 164, Number 2, 2004
ing the PP1 holoenzyme to dephosphorylate T RI, as PP1c
exhibits phosphatase activity only when it binds to its appro-
priate targeting subunit for specific substrate. Moreover,
overexpression of dominant-negative SARA with mutation of
PP1c-binding domain inhibits GADD34 complex–mediated
dephosphorylation (Fig. 5, a and b, lane 4) indicating that
SARA is likely a membrane anchor protein for PP1c. To in-
vestigate the potential role of SARA in recruitment of PP1c
to the GADD34 complex, both wild-type and dominant-
negative SARA were transfected into COS1 cells. As ex-
pected, the amount of PP1c in the complex was increased by
addition of wild-type SARA and decreased by addition of
dominant-negative SARA (Fig. 5 c). Together, these results
suggest that PP1c is handed over to the targeting subunit
GADD34 through SARA. In an in vivo phosphatase assay
similar to experiment in Fig. 4 c, the effect of SARA on T RI
dephosphorylation was examined. Dominant-negative SARA
suppressed the dephosphorylation of T RI (Fig. 5, d and e).
SARA appears to facilitate the dephosphorylation of T RI in
the Smad7-negative feedback loop by controlling the specific
subcellular localization of PP1c.
GADD34–PP1c recruited by Smad7 inhibits TGF -
induced cell cycle arrest and mediates TGF  resistance
Finally, we attempted to characterize cellular function
GADD34–PP1c in TGF  signaling. First, we examined the
effects of dephosphorylation of T RI on TGF -induced
gene transactivation. A TGF -responsive p3TP luciferase
reporter construct was cotransfected into Mv1Lu cells with
Smad7, GADD34, PP1, and/or dominant-negative SARA
(Fig. 6 a). As expected, GADD34 or Smad7 alone inhibited
TGF -induced transcription activation (Fig. 6 a, lanes 2
and 3). Furthermore, transactivation was almost completely
blocked when Smad7 was coexpressed with either GADD34
or GADD34 and PP1c or GADD34 and SARA, whereas
dominant-negative GADD34, Smad7, and SARA or OA re-
versed the Smad–GADD34-mediated inhibition to varying
extents. As we know, TGF  induces epithelial cell cycle ar-
rest. GADD34–PP1c could inhibit such effect because the
complex negatively regulates TGF -induced gene transcrip-
tion. We then examined the effect of GADD34–PP1c com-
plex on TGF -induced epithelium cell cycle arrest. Cells
were cotransfected with Smad7, GADD34, PP1, and/or
dominant-negative SARA as luciferase assay; GFP was also
cotransfected for sorting the transfected cells. After treat-
ment as indicated, cells were first sorted for cotransfected
GFP and then DNA contents were quantified by FACS
®
(Fig. 6 b). These results indicate that GADD34–PP1c in-
hibits TGF -induced epithelium cell cycle arrest.
Considering GADD34 is a growth-arrested and DNA-
damaged protein induced by different stresses, such as UV
light and unfolded proteins, its involvement in here pro-
posed complex implies that the regulation of TGF  signal-
ing by this PP1 complex may play an important role in
stress-induced cell response. Interestingly, GADD34 and
Smad7 expression can simultaneously be induced by UV
light irradiation (Hollander et al., 1997; Quan et al., 2001).
Furthermore, UV light irradiation–induced Smad7 is re-
sponsible for TGF  resistance in the UV light–irradiated
cells (Quan et al., 2001). We therefore examined whether
the resistance to TGF  is correlated with the induction of
GADD34 and Smad7. We first transfected the cells with the
constructs, including siRNA against Smad7 and GADD34,
as indicated, and then exposed the cell to UV light to induce
the GADD34 and Smad7 expression, which will cause
TGF  resistance in irradiated cells. Our luciferase assay in-
dicates Smad7 and GADD34 are involved in TGF  re-
sistance in responding to UV light irradiation (Fig. 6 c)
and that blockade of UV light–enhanced expression of
GADD34 restores UV light–inhibited Smad2 nuclear trans-
location and downstream PAI-1 expression (Fig. 6 d).
Discussion
Precise control of cascade amplification of phosphorylation
from receptor to R-Smad is a crucial component of the
TGF  signaling pathway (Wrana et al., 1992, 1994a;
Wieser et al., 1995; Abdollah et al., 1997; Heldin et al.,
1997; Attisano and Wrana, 2002). Here, we proposed a
novel mechanism of Smad7-mediated dephosphorylation of
T RI. We first found Smad7 interacts with GADD34, a
regulatory/targeting subunit of PP1 holoenzyme, and dem-
onstrated the existence of an endogenous T RI–Smad7–
GADD34 triple complex, whose presence is regulated by
TGF  via its induction of Smad7. We then showed that this
triple complex recruited a catalytic subunit of protein
phosphatase1 (PP1c). Both in vitro and in vivo dephosphor-
ylation assays demonstrated that the PP1 holoenzyme de-
phosphorylates T RI, down-regulating the TGF  signaling
pathway. Smad7 acts as an adaptor protein for the formation
of the complex and subsequent T RI dephosphorylation
(Fig. 7). Dephosphorylation of T RI by Smad7-induced
PP1c complex explains the central role that Smad7 plays in
the negative feedback mechanism.
SARA was originally known as a membrane-bound an-
chor protein for the recruitment of R-Smads and PP1c
(Tsukazaki et al., 1998; Bennett and Alphey, 2002). Muta-
tion in SARA’s PP1c binding site (F728A) inhibited the re-
cruitment of PP1c to the triple complex. Overexpression of
wild-type SARA, however, enhanced the interaction of PP1c
with the triple complex, consequently enhancing the de-
phosphorylation of T RI. Importantly, we also found that
the SARA–PP1c complex is not able to dephosphorylate
T RI directly. SARA is not a targeting subunit of PP1 to
dephosphorylate T RI. GADD34 is the essential targeting
subunit of the PP1 holoenzyme, directing PP1c-mediated
T RI dephosphorylation. SARA appears to serve only as an
anchor protein to enhance the availability of PP1c to
GADD34 (Fig. 7). A previous study has shown that
R-Smads interact with and are recruited by SARA, but once
phosphorylated by T RI, they dissociate from SARA to
form a complex with Smad4. So, phosphorylated R-Smad is
not a component of this PP1 holoenzyme complex.
It seems that there are three mechanisms by which Smad7
negatively regulates TGF  signaling: (1) mechanical block-
age of R-Smad’s phosphorylation, (2) proteasomal degrada-
tion, and (3) dephosphorylation of T RI. Smad7 was ini-
tially found involved in the regulation of a variety of
physiological and pathological processes such as shear stressDephosphorylation of T RI by GADD34–PP1c | Shi et al. 297
in the vascular epithelium (Topper et al., 1997; Ishisaki et
al., 1998; Kleeff et al., 1999; Nakao et al., 1999). It func-
tions as an intracellular receptor antagonists by binding
stably to activated T RI to prevent phosphorylation of
R-Smads. The physical blocking of T RI requires the inter-
action between Smad7 and T RI, which is also the initial
step of the PP1c complex–mediated dephosphorylation. This
mechanism may explain why Smad7 binds to phosphory-
lated T RI with a much higher affinity than to dephos-
phorylated T RI. TGF  ignites the phosphorylation T RI
with subsequent signaling and induction of Smad7, which
further initiates the formation of GADD34–PP1 complex
for T RI dephosphorylation. Therefore, it is likely that the
phosphorylation state of T RI regulates the interaction be-
tween Smad7 and T RI. So, dominant-negative GADD34
inhibits the dephosphorylation of T RI, which leads to a
longer stable association of Smad7 with phosphorylated
T RI, inhibiting TGF  signaling. This could be the reason
Figure 6. GADD34–PP1c recruited by Smad7 inhibits TGF  
signaling by dephosphorylating T RI and its induced cell cycle 
arrest and it contributes to UV light–induced TGF  resistance. 
(a) Mv1Lu cells were transfected with 3TP–lux alone or together 
with the indicated amounts of expression constructs for different 
genes. Transfected cells were incubated in the presence (black bars) 
or absence (open bars) of TGF -1. Luciferase activity was normalized 
and plotted as the mean   SD of triplicates from a representative 
experiment. (b) GADD34–PP1c recruited by Smad7 inhibits anti-
proliferative effect of TGF  on Mv1Lu cells. Transfected cells with 
different combinations of expression constructs for different genes 
were incubated in the presence or absence of TGF -1, harvested 2 d 
after transfection, and then subjected to FACS
®–DNA profiling as-
say. The percentage of cells in G1 phase was plotted as the mean   
SD of triplicates from a representative experiment. (c) Knockdown
of Smad7 and GADD34 expression resensitizes TGF  signaling in 
UV light–irradiated cells. The day before UV light irradiation, HepG2 cells were transfected with 3TP–lux together with the indicated siRNAs 
or scrambled dsRNA. 24 h after UV light irradiation, luciferase activity was assayed and normalized and plotted as the mean   SD of triplicates 
from a representative experiment. *P   0.05, compared with lane 2. (d) UV light irradiation inhibits Smad2 nuclear translocation and down-
stream gene expression, while blocking UV light–enhanced expression of Smad7 or GADD34 rescues it. HepG2 Cells were transfected with 
siRNA against Smad7 or GADD34 the day before UV light irradiation. The cells were stimulated by TGF  for 2 h (Smad2 translocation) or 24 h 
(PAI-1 induction) after UV light irradiation. Immunostaining were then performed to visualize the intracellular translocation of Smad2 and
expression of PAI-1. (e) GADD34 induced by UV light irradiation is knocked down by RNAi. GFP expression vector (one tenth the amount 
of siRNA) was cotransfected into HepG2 cells with siRNA against GADD34. The siRN-transfected cell (last column, showing GFP positive) 
showed less expression of GADD34, whereas the siRNA-untransfected cell (last column, showing GFP negative, at bottom of the panel) with 
GADD34 intact compared with siRNA-untransfected UV light–irradiated cell in middle column.298 The Journal of Cell Biology | Volume 164, Number 2, 2004
that dominant-negative GADD34 with an absent PP1c
binding site appears not efficiently rescue the inhibition of
TGF  signaling in transcriptional response and cell cycle as-
says. This observation is further confirmed by the fact that
the blocking of GADD34 expression by RNAi eliminates
the effect of dnGADD34 in the UV light irradiation experi-
ment. Physical blockage is only one step of Smad7 inhibi-
tion, and each Smad7 molecule can only inhibit one T RI
receptor in the physical blockage model. Whereas, the in-
volvement of PP1c dephosphorylation, Smad7 could inhibit
T RI much more efficiently through enzymatic activity. In
the third proteasome degradation mechanism, Smad7 was
found to act as an adaptor protein to bind to Smurf2 to
form an E3 ubiquitin ligase that targets T RI for its degra-
dation (Kavsak et al., 2000). This is an irreversible and ter-
minal destruction of T RI, a different level of regulation.
Because cytokines such as interferon   and TNF  also in-
duce Smad7 expression, and T RI is occasionally phosphor-
ylated by constitutively active type II receptor (T RII; Ven-
tura et al., 1994; Chen et al., 1995) or other kinases in the
absence of ligands (Topper et al., 1997; Ulloa et al., 1999;
Zhang and Derynck, 1999; Bitzer et al., 2000), there is a
basal level of induced Smad7 expression. Importantly, the
interaction between ubiquitin ligase Smurf2 and Smad7 is
induced by IFN . Therefore, the mechanism by which
Smad7 targets T RI for degradation is important for the
turnover of T RI and IFN -dependent inhibition of TGF 
signaling (Kavsak et al., 2000). Our data show this basal
level Smad7 still mediates the recruitment of PP1 holoen-
zyme to minimize the background signaling initiated by ran-
dom, promiscuous phosphorylation of T RI, which may in
turn be important for maintenance of cell function. Taken
together, these data imply that Smad7, in different cellular
contexts, differentially regulates cellular activity by a prefer-
ential mechanism, although all three mechanisms may act si-
multaneously to contribute to the final response of the cell.
GADD34 was initially reported to be induced by various
types of cellular stress and DNA damage, such as UV light ir-
radiation and unfolded proteins, and its function in overcom-
ing a protein synthesis checkpoint is supported by the fact
that the  (1)34.5 domain necessary for averting the total shut-
off of protein synthesis in herpes simplex virus–infected cells
maps to the COOH-terminal domain of the  (1)34.5 pro-
tein. This region is highly homologous to the corresponding
domains in MyD116 and GADD34 (He et al., 1998). More-
over, GADD34 has been implicated in the dephosphorylation
of eIF2  in a negative feedback loop that inhibits stress-
induced gene expression and that might promote recovery from
translational inhibition in the unfolded protein response (No-
voa et al., 2001). The involvement of GADD34 in our pro-
posed complex implies that the regulation of TGF  signaling
by this PP1 complex may play an important role in stress-
induced cell response. Interestingly, GADD34 and Smad7
expression can simultaneously be induced by UV light irradia-
tion (Hollander et al., 1997; Quan et al., 2001). Furthermore,
cellular stress caused by UV light irradiation has been known
to confer TGF  resistance in Mv1Lu cells (Quan et al.,
2001). UV light–induced TGF  resistance in Mv1Lu cells is
likely attributable to up-regulated expressions of Smad7 and
GADD34 and that disruption of this up-regulation will resen-
sitize the cell to TGF  signaling. Blocking expression of
GADD34 and Smad7 with RNAi not only restored TGF 
signaling in UV light–irradiated cells, but rescued the sup-
pressed expression of downstream gene, PAI-1. Dephosphory-
lation of T RI by Smad7-mediated PP1 complex is a quick
reversible mechanism and it plays a very important role in reg-
ulating TGF  signaling in certain cellular context, such as cel-
lular stress, DNA damage, and induced growth arrest, which
further indicates the diversity of cell growth regulation under
different cellular context. It will be of substantial interest
to investigate the role of our proposed complex in the tu-
morigenesis of some TGF -resistant tumors, developmental
events, and other TGF -mediated disorders.
Materials and methods
Yeast two-hybrid assay
A full-length wild-type Smad7 coding sequence was cloned into pGBKT7
(CLONTECH Laboratories, Inc.) to generate the bait plasmid with which a
human chondrocyte cDNA library was screened according to the manu-
facturer’s instructions (CLONTECH Laboratories, Inc.). The interaction be-
tween Smad7 and GADD34 were further confirmed with a  -gal filter lift
assay and quantified by a liquid  -gal assay according to the manufac-
turer’s instructions (CLONTECH Laboratories, Inc.). Liquid  -gal assay was
also performed for Smad7 and GADD34 interaction domain analysis by
using different truncation mutations of Smad7 and GADD34.
Immunoprecipitation and immunoblotting
Cells transfected by LipofectAMINE (GIBCO BRL) were lysed with radioim-
mune precipitation buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1%
Nonidet-P-40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease
inhibitors (as described above for cell homogenization) and phosphatase
inhibitors (10 mM sodium orthovanadate, 1  M OA, and 50 mM sodium
 -glycerophosphate). Lysates were immunoprecipiated by incubation with
the appropriate antibodies, followed by adsorption to protein G Sepharose.
Immunoprecipitates were separated by SDS-PAGE, blotted onto a PVDF
(Bio-Rad Laboratories) membrane, and visualized by enhanced chemilu-
minescence (ECL Kit; Amersham Biosciences). For mapping the interaction
domains between Smad7 and GADD34 in mammalian cells, a series of
different deletion constructs were epitope tagged with Flag or HA and sub-
cloned into pcDNA3. All immunoprecipitation and blotting antibodies
were obtained from commercial sources: monoclonal anti–Flag M2
and anti– -actin (Sigma-Aldrich), anti-HA (Babco), polyclonal anti-T RI
(Genex Bioscience, Inc.), polyclonal goat anti-Smad7, polyclonal anti-
GADD34, and monoclonal anti-PP1 (Santa Cruz Biotechnology, Inc.).
RNAi
To silence endogenous Smad7 and GADD34 expression, single-stranded
21-nt RNAs directed against Smad7 and GADD34 were chemically syn-
thesized and purified (Ambion). The target sequences were 5 -AGGUCAC-
CACCAUCCCCACUU-3  and 5 -GUCAAUUUGCAGAUGGCCAUU-3 ,
respectively. siRNA duplexes were generated and transfected into cells us-
ing the Silencer
TM siRNA transfection kit (Ambion) according to the manu-
facturer’s instructions. The amount of transfected siRNA was kept constant
by addition of scrambled dsRNA provided by the manufacturer.
Figure 7. A model for dephosphorylation of T RI by Smad7-mediated 
PP1 holoenzyme in TGF  signaling. See Discussion for details. SBD, 
Smad-binding domain; PBD, phosphatase-binding domain; CTD, 
COOH-terminal domain; NTD, NH2-terminal domain.Dephosphorylation of T RI by GADD34–PP1c | Shi et al. 299
In vitro phosphorylation and dephosphorylation
GST-T RI was purified from bacterial lysates by absorption to glutathione–
agarose beads as described elsewhere (He et al., 1996). GST–T RI beads
were washed with phosphorylation buffer (25 mM Tris-HCl, pH 7.5, 10
mM MgCl2, 2 mM MnCl2, 0.4 mM EDTA, 1 mM dithiothreitol, 2 mM
orthovanadate, 10 mM NaF, 5 mM  -glycerophosphate, and 10  M ATP)
containing a protease inhibitor mixture (1 mM phenylmethylsulfonyl fluo-
ride and 10  g/ml antipain, chymostatin, leupeptin, and pepstatin A). 50
 Ci of [ 
32P]ATP was then added to the mixture and incubated for 20 min
at 30 C with anti-HA precipitates of T RII–HA-transfected cells and pro-
tein G–Sepharose beads. The protein G–Sepharose beads and particulate
material were pelleted at 14,000 g for 20 min, washed again with dephos-
phorylation buffer (20 mM Tris-HCl, pH 7.4, 50 mM KCl, 2 mM MgCl2, 0.1
mM EDTA, 0.8 mM ATP), and incubated in the same buffer with different
precipitates from cells transfected with the indicated genes in the presence
or absence of 0.05  M recombinant PP1 catalytic subunit (  isoform from
rabbit; Sigma-Aldrich) or its inhibitors (1.0  M OA and 50 nM I-1; Sigma-
Aldrich). Phosphorylation status was analyzed on an 8.5% SDS-PAGE gel
and autoradiography. Phosphatase activity of the precipitates was deter-
mined by phosphorylation status of the supposed substrate, T RI–HA.
Metabolic 
32P labeling and in vivo phosphorylation state detection
36 h after transfection with different combination of genes, cells were
washed twice with phosphate-free DME containing 2% dialyzed fetal calf
serum, incubated in the same medium for 4 h, and then labeled with 1
mCi/ml [
32P]orthophosphate (PerkinElmer) for an additional 2 h at 37 C in
the absence or presence of TGF -1. The cells were washed again with the
same medium and incubated with regular DME/ 2% FBS for another 2 h
with or without PP1 inhibitor treatment. The 
32P-labeled cells were then
washed with ice-cold PBS and lysed with radioimmunoprecipitation assay
buffer. T RI–HA was immunoprecipitated with anti-HA as described
above. The resultant precipitates were separated by 8.5% SDS-PAGE. Gels
were dried and exposed to Biomax Mr or MS film (Eastman Kodak Co.). Af-
ter autoradiographic analysis, dried gels were rehydrated with transfer
buffer, and transferred onto PVDF membranes. For equal loading confir-
mation, the transfected T RI–HA was visualized by the ECL
Plus Western
blotting detection system (Amersham Biosciences).
Transcriptional response assay
Mv1Lu cells were transiently transfected either with 3TP-Lux alone or to-
gether with indicated constructs using LipofectAMINE (GIBCO BRL) trans-
fection. Total DNA was kept constant by the addition of pcDNA3 plasmid.
24 h after transfection, cells were incubated overnight with or without 4
ng/ml TGF -1. Luciferase activity was measured using the Dual Luciferase
assay kit (Promega) according to the manufacturer’s instructions.
Cell cycle analysis
Transfected cells were harvested in PBS containing 0.1% BSA and then
washed once in PBS containing 1% FBS, centrifuged, resuspended in 0.5
ml of PBS, and fixed by adding 5 ml of cold absolute ethanol. Fixed cells
were stored at 4 C until the time of analysis. Immediately before analysis
on the flow cytometer, the fixed cells were centrifuged at 1,600 rpm for 5
min, washed once with PBS/1% FBS, and then incubated at 37 C for 2 h in
propidium iodide/RNase A solution (10  g/ml propidium iodide in 0.76
mM sodium citrate at pH 7.0; 100 ng/ml RNase A in 10 mM Tris-HCl, 15
mM NaCl at pH 7.5) diluted into PBS/1% FBS. Cells were first sorted for
cotransfected GFP and then DNA contents were quantified. FACS
® sorting
was performed on a FACStar
® machine and analyzed with CellQuest pro-
gram.
UV light irradiation
Subconfluent cells were incubated in serum-free medium overnight. The
next morning, the media were removed and cells were covered with a thin
layer of PBS and irradiated with UV light (20 mJ/cm
2) using four
FS24T12UVB-HO bulbs. A Kodacel filter was used to eliminate wave-
lengths below 290 nm (UVC). The irradiation intensity was monitored with
an IL400A radiometer and a SED240/UVB/W photodetector (International
Light). After irradiation, the PBS was replaced with the original media. Cel-
lular viability 24 h after UV light irradiation was near 100% based on cell
morphology and number. For luciferase assay, the day before UV light irra-
diation, cells were transfected with 3-TP luciferase reporter construct and
TGF -1 (4 ng/ml) was added after UV light irradiation overnight before lu-
ciferase activity assay. siRNA was transfected the day before UV light irra-
diation.
Immunolocalization
After UV light irradiation and ligand stimulation, cells were fixed in 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100 on ice in block-
ing buffer (10%BSA in PBS), and labeled with antibodies in PBS with 2%
BSA. GADD34 was visualized by immunostaining with rabbit antibody
against GADD34 (Santa Cruz) and goat anti–rabbit Texas red–conjugated
IgG (Amersham Biosciences). For Smad2 translocation observation, TGF -
1 (4 ng/ml) was added for 2 h after UV light irradiation, and phosphory-
lated Smad2 was visualized by immunostaining with rabbit antibody
against phosphorylated Smad2 at 465 and 467 residues (Biosource Interna-
tional) and goat anti–rabbit fluorescein-conjugated IgG. For PAI-1 induc-
tion observation, immunostaining performed with antibodies (rabbit anti–
PAI-1 from Santa Cruz; goat anti–rabbit fluorescein-conjugated IgG from
Amersham Biosciences) 24 h after UV light irradiation. Digital pictures
were taken with an Olympus, IX TRINOC camera under Olympus, IX70
Inverted Research Microscope (Olympus) with objective lenses of Hoff-
man Modulation Contrast 
®, HMC 10 LWD PL FL, 0.3NA  /1, OPTICS INC
at room temperature, and proceeded with MagnaFire
® SP imaging software
(Optronics).
Online supplemental material
Cultured cells were homogenized and fractionated as described previously
(Chan and Leder, 1996). Fractions were collected and analyzed by Western
blotting. Online supplemental material available at http://www.jcb.org/cgi/
content/full/jcb.200307151/DC1.
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